0001493152-22-024345.txt : 20220830
0001493152-22-024345.hdr.sgml : 20220830
20220830080023
ACCESSION NUMBER: 0001493152-22-024345
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220830
DATE AS OF CHANGE: 20220830
EFFECTIVENESS DATE: 20220830
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-457338
FILM NUMBER: 221212911
BUSINESS ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 623
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 623
CITY: BALTIMORE
STATE: MD
ZIP: 21205
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences, Inc.
DATE OF NAME CHANGE: 20170413
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
D
1
primary_doc.xml
X0708
D
LIVE
0001321834
MyMD Pharmaceuticals, Inc.
855 N. WOLFE STREET
SUITE 601
BALTIMORE
MD
MARYLAND
21205
(856) 848-8698
NEW JERSEY
None
Akers Biosciences, Inc.
Akers Biosciences Inc
Corporation
true
Chris
Chapman
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Executive Officer
Director
Director, President and Chief Medical Officer
Adam
Kaplin
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Executive Officer
Chief Scientific Officer
Paul
Rivard
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Executive Officer
Executive Vice President of Operations and General Counsel
Ian
Rhodes
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Executive Officer
Interim Chief Financial Officer
Craig
Eagle
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Director
Christopher
Schreiber
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Director
Joshua
Silverman
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Director
Chairman of the Board
Jude
Uzonwanne
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Director
Bill
White
855 N. Wolfe Street
Suite 601
Baltimore
MD
MARYLAND
21205
Director
Other Health Care
Decline to Disclose
- 06b
false
2022-08-15
false
true
true
false
0
Dawson James Securities, Inc.
130645
None
None
101 NORTH FEDERAL HIGHWAY
SUITE 600
BOCA RATON
FL
FLORIDA
33432
CT
CONNECTICUT
FL
FLORIDA
IL
ILLINOIS
NY
NEW YORK
false
7411761
0
7411761
Represents warrants to purchase up to 1,411,764 shares of common stock at $5.25/share.
false
8
239999
0
0
false
MyMD Pharmaceuticals, Inc.
/s/ Chris Chapman
Chris Chapman
President, Chief Medical Officer, and Director
2022-08-30